{rfName}
Dr

Indexed in

License and use

Icono OpenAccess

Citations

9

Altmetrics

Analysis of institutional authors

Garcia-Mulero, SAuthorVarela, MAuthorDel Carpio, LpAuthorMoreno, RAuthorCosta-García, MAuthorAlemany, RAuthorPiulats, JmCorresponding AuthorSanz-Pamplona, RCorresponding Author

Share

Publications
>
Article

Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients

Publicated to:Oncoimmunology. 12 (1): 2261278- - 2023-12-31 12(1), DOI: 10.1080/2162402X.2023.2261278

Authors: García-Mulero, S; Fornelino, R; Punta, M; Lise, S; Varela, M; del Carpio, LP; Moreno, R; Costa-García, M; Rieder, D; Trajanoski, Z; Gros, A; Alemany, R; Piulats, JM; Sanz-Pamplona, R

Affiliations

Abstract

Keywords

AdultAmino acid sequenceArticleBinding affinityBioinformaticsCancer immunotherapyCancer patientCancer riskCancer survivalCd8+ t lymphocyteCell infiltrationDifferential expression analysisGene frequencyGene mutationGene overexpressionGene set enrichment analysisGeneticsGenomicsGenotypeGna11Gna11 protein, humanGnaqGnaq protein, humanGtp-binding protein alpha subunitsGtp-binding protein alpha subunits, gq-g11Guanine nucleotide binding proteinGuanine nucleotide binding protein alpha subunitHaplotypeHlaHla a antigenHla antigenHla b antigenHumanHumansImmune systemImmunocompetent cellImmunogenicityImmunotherapyImproved predictionsKaplan meier methodMachine learningMetabolismMetastasisMutationNatural killer cellNeoantigenNeural-networksOverall survivalPd-1PhenotypePredictionProportional hazards modelRank sum testRecurrence free survivalRna sequencingSurvivalT-cell epitopesTranscriptomicsTumor microenvironmentUnivariate analysisUvea melanomaUvea tumorUveal melanomaUveal neoplasmsVaccination

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Oncoimmunology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2023, it was in position 45/322, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 2.61, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-29, the following number of citations:

  • WoS: 4
  • Scopus: 4
  • Europe PMC: 1
  • OpenCitations: 2

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-29:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 16.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 16 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 6.55.
  • The number of mentions on the social network X (formerly Twitter): 9 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Austria; United Kingdom.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (GARCIA MULERO, SANDRA) and Last Author (SANZ PAMPLONA, REBECA).

the authors responsible for correspondence tasks have been Piulats Rodriguez, Jose Maria and SANZ PAMPLONA, REBECA.